MeSH D001523 - mental disorders
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D001523:
Mental disorders
0 Companies
0 Drugs
Success rate
D000068079:Motor disorders
0 Companies
0 Drugs
Success rate
D000068099:Trauma and stressor related disorders
0 Companies
0 Drugs
Success rate
D001008:Anxiety disorders
D001068:Feeding and eating disorders
D004213:Dissociative disorders
0 Companies
0 Drugs
Success rate
D007174:Impulse control disruptive and conduct disorders
0 Companies
0 Drugs
Success rate
D009497:Neurotic disorders
0 Companies
0 Drugs
Success rate
D010262:Paraphilic disorders
0 Companies
0 Drugs
Success rate
D010554:Personality disorders
0 Companies
0 Drugs
Success rate
D012893:Sleep wake disorders
D013001:Somatoform disorders
0 Companies
0 Drugs
Success rate
D019960:Elimination disorders
0 Companies
0 Drugs
Success rate
D019964:Mood disorders
D019965:Neurocognitive disorders
0 Companies
0 Drugs
Success rate
D019966:Substance-related disorders
D019967:Schizophrenia spectrum and other psychotic disorders
D065886:Neurodevelopmental disorders
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
54%7/13
Phase 2
42%5/12
Phase 3
56%9/16
Approved: 0Overall Success rate: 13%
All Clinical Trials
No data
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use